5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the FDA since Dec. 13.  

1. Giapreza is an injection that increases blood pressure in adults with septic or other distributive shock.

2. Ixifi, Pfizer's biosimilar version of Johnson & Johnson's immunosuppressive drug Remicide, is intended to treat rheumatoid arthritis, Crohn's disease and plaque psoriasis.

3. A novel gene therapy, Luxturna, treats a rare form of inherited vision loss that can result in complete blindness.

4. Nucala, a drug that treats severe asthma, is now approved to treat a rare autoimmune disease, eosinophilic granulomatosis with polyangiitis, which causes vasculitis, an inflammation in the wall of blood vessels. 

6. Steglatro, approved to treat Type 2 diabetes, is a SGLT2 inhibitor, which works by causing patients to expel excess glucose through their urine.

More articles on supply chain:
Pfizer authorizes $10B share buyback
Two months after approval, Gilead's 'breakthrough' cancer drug given to just a handful of patients
FDA launches website to improve management of antibiotic use

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months